雍禾医疗集团有限公司（02279）于2025年12月2日向香港联合交易所有限公司提交了截至2025年11月30日的股份变动月报表。根据公告，报告期内公司未发生新增股份发行、购回或注销行为，整体股本结构保持稳定。
\n\n公告显示，公司法定注册股本维持在20,000,000,000股，面值为每股0.0000025美元，总额约为50,000美元；已发行股份数目为525,224,416股，库存股份数目为248,000股，两者与上月均无变化。
\n\n报告指出，本月无进一步发行股份期权或其他涉及公司股份的协定，也未实施任何购回或注销股份动作，期末股本总数依旧为525,472,416股，公司整体股本状况未出现波动。
\n\n公告由公司董事张玉呈交并确认遵守香港联交所上市规则及相关法律法规的要求。公司方面暂无进一步变动计划。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.